Minthon L

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (31)

Title : Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement - Wattmo_2018_Curr.Alzheimer.Res_15_905
Author(s) : Wattmo C , Londos E , Minthon L
Ref : Curr Alzheimer Res , 15 :905 , 2018
Abstract : Wattmo_2018_Curr.Alzheimer.Res_15_905
ESTHER : Wattmo_2018_Curr.Alzheimer.Res_15_905
PubMedSearch : Wattmo_2018_Curr.Alzheimer.Res_15_905
PubMedID: 29732972

Title : Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death - Wattmo_2016_BMC.Neurol_16_156
Author(s) : Wattmo C , Londos E , Minthon L
Ref : BMC Neurol , 16 :156 , 2016
Abstract : Wattmo_2016_BMC.Neurol_16_156
ESTHER : Wattmo_2016_BMC.Neurol_16_156
PubMedSearch : Wattmo_2016_BMC.Neurol_16_156
PubMedID: 27581368

Title : Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy - Wattmo_2016_Alzheimers.Res.Ther_8_7
Author(s) : Wattmo C , Minthon L , Wallin AK
Ref : Alzheimers Res Ther , 8 :7 , 2016
Abstract : Wattmo_2016_Alzheimers.Res.Ther_8_7
ESTHER : Wattmo_2016_Alzheimers.Res.Ther_8_7
PubMedSearch : Wattmo_2016_Alzheimers.Res.Ther_8_7
PubMedID: 26883213

Title : Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services - Wattmo_2015_Dement.Geriatr.Cogn.Disord_40_297
Author(s) : Wattmo C , Londos E , Minthon L
Ref : Dementia & Geriatric Cognitive Disorders , 40 :297 , 2015
Abstract : Wattmo_2015_Dement.Geriatr.Cogn.Disord_40_297
ESTHER : Wattmo_2015_Dement.Geriatr.Cogn.Disord_40_297
PubMedSearch : Wattmo_2015_Dement.Geriatr.Cogn.Disord_40_297
PubMedID: 26335053

Title : Response to cholinesterase inhibitors affects lifespan in Alzheimer inverted question marks disease - Wattmo_2014_BMC.Neurol_14_173
Author(s) : Wattmo C , Londos E , Minthon L
Ref : BMC Neurol , 14 :173 , 2014
Abstract : Wattmo_2014_BMC.Neurol_14_173
ESTHER : Wattmo_2014_BMC.Neurol_14_173
PubMedSearch : Wattmo_2014_BMC.Neurol_14_173
PubMedID: 25213579

Title : Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services - Wattmo_2014_Clin.Interv.Aging_9_1951
Author(s) : Wattmo C , Londos E , Minthon L
Ref : Clin Interv Aging , 9 :1951 , 2014
Abstract : Wattmo_2014_Clin.Interv.Aging_9_1951
ESTHER : Wattmo_2014_Clin.Interv.Aging_9_1951
PubMedSearch : Wattmo_2014_Clin.Interv.Aging_9_1951
PubMedID: 25484578

Title : Risk Factors That Affect Life Expectancy in Alzheimer's Disease: A 15-Year Follow-Up - Wattmo_2014_Dement.Geriatr.Cogn.Disord_38_286
Author(s) : Wattmo C , Londos E , Minthon L
Ref : Dementia & Geriatric Cognitive Disorders , 38 :286 , 2014
Abstract : Wattmo_2014_Dement.Geriatr.Cogn.Disord_38_286
ESTHER : Wattmo_2014_Dement.Geriatr.Cogn.Disord_38_286
PubMedSearch : Wattmo_2014_Dement.Geriatr.Cogn.Disord_38_286
PubMedID: 24992891

Title : Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies - Wattmo_2013_Alzheimers.Res.Ther_5_44
Author(s) : Wattmo C , Wallin AK , Minthon L
Ref : Alzheimers Res Ther , 5 :44 , 2013
Abstract : Wattmo_2013_Alzheimers.Res.Ther_5_44
ESTHER : Wattmo_2013_Alzheimers.Res.Ther_5_44
PubMedSearch : Wattmo_2013_Alzheimers.Res.Ther_5_44
PubMedID: 24099236

Title : A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy - Wattmo_2013_Clin.Interv.Aging_8_329
Author(s) : Wattmo C , Paulsson E , Minthon L , Londos E
Ref : Clin Interv Aging , 8 :329 , 2013
Abstract : Wattmo_2013_Clin.Interv.Aging_8_329
ESTHER : Wattmo_2013_Clin.Interv.Aging_8_329
PubMedSearch : Wattmo_2013_Clin.Interv.Aging_8_329
PubMedID: 23682212

Title : Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease - Hoglund_2012_J.Alzheimers.Dis_32_939
Author(s) : Hoglund K , Bogstedt A , Fabre S , Aziz A , Annas P , Basun H , Minthon L , Lannfelt L , Blennow K , Andreasen N
Ref : J Alzheimers Dis , 32 :939 , 2012
Abstract : Hoglund_2012_J.Alzheimers.Dis_32_939
ESTHER : Hoglund_2012_J.Alzheimers.Dis_32_939
PubMedSearch : Hoglund_2012_J.Alzheimers.Dis_32_939
PubMedID: 22936008

Title : Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort - Wattmo_2012_BMC.Neurol_12_134
Author(s) : Wattmo C , Wallin AK , Minthon L
Ref : BMC Neurol , 12 :134 , 2012
Abstract : Wattmo_2012_BMC.Neurol_12_134
ESTHER : Wattmo_2012_BMC.Neurol_12_134
PubMedSearch : Wattmo_2012_BMC.Neurol_12_134
PubMedID: 23126532

Title : Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment - Wattmo_2011_Gerontologist_51_17
Author(s) : Wattmo C , Wallin AK , Londos E , Minthon L
Ref : Gerontologist , 51 :17 , 2011
Abstract : Wattmo_2011_Gerontologist_51_17
ESTHER : Wattmo_2011_Gerontologist_51_17
PubMedSearch : Wattmo_2011_Gerontologist_51_17
PubMedID: 20562471

Title : Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting - Wallin_2011_Neuropsychiatr.Dis.Treat_7_565
Author(s) : Wallin AK , Wattmo C , Minthon L
Ref : Neuropsychiatr Dis Treat , 7 :565 , 2011
Abstract : Wallin_2011_Neuropsychiatr.Dis.Treat_7_565
ESTHER : Wallin_2011_Neuropsychiatr.Dis.Treat_7_565
PubMedSearch : Wallin_2011_Neuropsychiatr.Dis.Treat_7_565
PubMedID: 22003296

Title : Predictors of long-term cognitive outcome in Alzheimer's disease - Wattmo_2011_Alzheimers.Res.Ther_3_23
Author(s) : Wattmo C , Wallin AK , Londos E , Minthon L
Ref : Alzheimers Res Ther , 3 :23 , 2011
Abstract : Wattmo_2011_Alzheimers.Res.Ther_3_23
ESTHER : Wattmo_2011_Alzheimers.Res.Ther_3_23
PubMedSearch : Wattmo_2011_Alzheimers.Res.Ther_3_23
PubMedID: 21774798

Title : Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease - Parnetti_2011_Acta.Neurol.Scand_124_122
Author(s) : Parnetti L , Chiasserini D , Andreasson U , Ohlson M , Huls C , Zetterberg H , Minthon L , Wallin AK , Andreasen N , Talesa VN , Blennow K
Ref : Acta Neurologica Scandinavica , 124 :122 , 2011
Abstract : Parnetti_2011_Acta.Neurol.Scand_124_122
ESTHER : Parnetti_2011_Acta.Neurol.Scand_124_122
PubMedSearch : Parnetti_2011_Acta.Neurol.Scand_124_122
PubMedID: 20880294

Title : A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease - Palmqvist_2010_Alzheimers.Res.Ther_2_29
Author(s) : Palmqvist S , Minthon L , Wattmo C , Londos E , Hansson O
Ref : Alzheimers Res Ther , 2 :29 , 2010
Abstract : Palmqvist_2010_Alzheimers.Res.Ther_2_29
ESTHER : Palmqvist_2010_Alzheimers.Res.Ther_2_29
PubMedSearch : Palmqvist_2010_Alzheimers.Res.Ther_2_29
PubMedID: 20950460

Title : The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease - Wiig_2010_Acta.Neurol.Scand_121_186
Author(s) : Wiig EH , Annas P , Basun H , Andreasen N , Lannfelt L , Zetterberg H , Blennow K , Minthon L
Ref : Acta Neurologica Scandinavica , 121 :186 , 2010
Abstract : Wiig_2010_Acta.Neurol.Scand_121_186
ESTHER : Wiig_2010_Acta.Neurol.Scand_121_186
PubMedSearch : Wiig_2010_Acta.Neurol.Scand_121_186
PubMedID: 19785641

Title : Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease - Wesnes_2010_Acta.Neurol.Scand_122_270
Author(s) : Wesnes K , Edgar C , Andreasen N , Annas P , Basun H , Lannfelt L , Zetterberg H , Blennow K , Minthon L
Ref : Acta Neurologica Scandinavica , 122 :270 , 2010
Abstract : Wesnes_2010_Acta.Neurol.Scand_122_270
ESTHER : Wesnes_2010_Acta.Neurol.Scand_122_270
PubMedSearch : Wesnes_2010_Acta.Neurol.Scand_122_270
PubMedID: 20047570

Title : CSF biomarkers predict a more malignant outcome in Alzheimer disease - Wallin_2010_Neurology_74_1531
Author(s) : Wallin AK , Blennow K , Zetterberg H , Londos E , Minthon L , Hansson O
Ref : Neurology , 74 :1531 , 2010
Abstract : Wallin_2010_Neurology_74_1531
ESTHER : Wallin_2010_Neurology_74_1531
PubMedSearch : Wallin_2010_Neurology_74_1531
PubMedID: 20458070

Title : Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease? - Wallin_2009_Int.J.Geriatr.Psychiatry_24_638
Author(s) : Wallin AK , Hansson O , Blennow K , Londos E , Minthon L
Ref : Int J Geriatr Psychiatry , 24 :638 , 2009
Abstract : Wallin_2009_Int.J.Geriatr.Psychiatry_24_638
ESTHER : Wallin_2009_Int.J.Geriatr.Psychiatry_24_638
PubMedSearch : Wallin_2009_Int.J.Geriatr.Psychiatry_24_638
PubMedID: 19123199

Title : The usefulness of cube copying for evaluating treatment of Alzheimer's disease - Palmqvist_2008_Am.J.Alzheimers.Dis.Other.Demen_23_439
Author(s) : Palmqvist S , Hansson O , Minthon L , Londos E
Ref : Am J Alzheimers Dis Other Demen , 23 :439 , 2008
Abstract : Palmqvist_2008_Am.J.Alzheimers.Dis.Other.Demen_23_439
ESTHER : Palmqvist_2008_Am.J.Alzheimers.Dis.Other.Demen_23_439
PubMedSearch : Palmqvist_2008_Am.J.Alzheimers.Dis.Other.Demen_23_439
PubMedID: 18955723

Title : Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting - Wattmo_2008_Dement.Geriatr.Cogn.Disord_26_203
Author(s) : Wattmo C , Hansson O , Wallin AK , Londos E , Minthon L
Ref : Dementia & Geriatric Cognitive Disorders , 26 :203 , 2008
Abstract : Wattmo_2008_Dement.Geriatr.Cogn.Disord_26_203
ESTHER : Wattmo_2008_Dement.Geriatr.Cogn.Disord_26_203
PubMedSearch : Wattmo_2008_Dement.Geriatr.Cogn.Disord_26_203
PubMedID: 18769065

Title : Longitudinal stability of CSF biomarkers in Alzheimer's disease - Blennow_2007_Neurosci.Lett_419_18
Author(s) : Blennow K , Zetterberg H , Minthon L , Lannfelt L , Strid S , Annas P , Basun H , Andreasen N
Ref : Neuroscience Letters , 419 :18 , 2007
Abstract : Blennow_2007_Neurosci.Lett_419_18
ESTHER : Blennow_2007_Neurosci.Lett_419_18
PubMedSearch : Blennow_2007_Neurosci.Lett_419_18
PubMedID: 17482358

Title : Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment - Darreh-Shori_2006_J.Neural.Transm.(Vienna)_113_1791
Author(s) : Darreh-Shori T , Meurling L , Pettersson T , Hugosson K , Hellstrom-Lindahl E , Andreasen N , Minthon L , Nordberg A
Ref : J Neural Transm (Vienna) , 113 :1791 , 2006
Abstract : Darreh-Shori_2006_J.Neural.Transm.(Vienna)_113_1791
ESTHER : Darreh-Shori_2006_J.Neural.Transm.(Vienna)_113_1791
PubMedSearch : Darreh-Shori_2006_J.Neural.Transm.(Vienna)_113_1791
PubMedID: 16868793

Title : Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study - Winblad_2006_Lancet_367_1057
Author(s) : Winblad B , Kilander L , Eriksson S , Minthon L , Batsman S , Wetterholm AL , Jansson-Blixt C , Haglund A
Ref : Lancet , 367 :1057 , 2006
Abstract : Winblad_2006_Lancet_367_1057
ESTHER : Winblad_2006_Lancet_367_1057
PubMedSearch : Winblad_2006_Lancet_367_1057
PubMedID: 16581404

Title : Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy - Wallin_2004_Dement.Geriatr.Cogn.Disord_18_197
Author(s) : Wallin AK , Gustafson L , Sjogren M , Wattmo C , Minthon L
Ref : Dementia & Geriatric Cognitive Disorders , 18 :197 , 2004
Abstract : Wallin_2004_Dement.Geriatr.Cogn.Disord_18_197
ESTHER : Wallin_2004_Dement.Geriatr.Cogn.Disord_18_197
PubMedSearch : Wallin_2004_Dement.Geriatr.Cogn.Disord_18_197
PubMedID: 15211076

Title : Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors - Parnetti_2002_Neurol.Sci_23_S95
Author(s) : Parnetti L , Amici S , Lanari A , Romani C , Antognelli C , Andreasen N , Minthon L , Davidsson P , Pottel H , Blennow K , Gallai V
Ref : Neurol Sci , 23 :S95 , 2002
Abstract : Parnetti_2002_Neurol.Sci_23_S95
ESTHER : Parnetti_2002_Neurol.Sci_23_S95
PubMedSearch : Parnetti_2002_Neurol.Sci_23_S95
PubMedID: 12548360

Title : Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease - Davidsson_2001_Neurosci.Lett_300_157
Author(s) : Davidsson P , Blennow K , Andreasen N , Eriksson B , Minthon L , Hesse C
Ref : Neuroscience Letters , 300 :157 , 2001
Abstract : Davidsson_2001_Neurosci.Lett_300_157
ESTHER : Davidsson_2001_Neurosci.Lett_300_157
PubMedSearch : Davidsson_2001_Neurosci.Lett_300_157
PubMedID: 11226635

Title : Long-term effects of tacrine on regional cerebral blood flow changes in Alzheimer's disease - Minthon_1995_Dementia_6_245
Author(s) : Minthon L , Nilsson K , Edvinsson L , Wendt PE , Gustafson L
Ref : Dementia , 6 :245 , 1995
Abstract : Minthon_1995_Dementia_6_245
ESTHER : Minthon_1995_Dementia_6_245
PubMedSearch : Minthon_1995_Dementia_6_245
PubMedID: 8528370

Title : Tacrine treatment modifies cerebrospinal fluid neuropeptide levels in Alzheimer's disease - Minthon_1994_Dementia_5_295
Author(s) : Minthon L , Edvinsson L , Gustafson L
Ref : Dementia , 5 :295 , 1994
Abstract : Minthon_1994_Dementia_5_295
ESTHER : Minthon_1994_Dementia_5_295
PubMedSearch : Minthon_1994_Dementia_5_295
PubMedID: 7866482

Title : Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG - Minthon_1993_Dementia_4_32
Author(s) : Minthon L , Gustafson L , Dalfelt G , Hagberg B , Nilsson K , Risberg J , Rosen I , Seiving B , Wendt PE
Ref : Dementia , 4 :32 , 1993
Abstract : Minthon_1993_Dementia_4_32
ESTHER : Minthon_1993_Dementia_4_32
PubMedSearch : Minthon_1993_Dementia_4_32
PubMedID: 8358504